カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の光開始剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Photoinitiator Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19543）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19543
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の光開始剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

光開始剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の光開始剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

光開始剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・フォトフリン、レブラン、メトビックス、その他

用途別セグメントは次のように区分されます。
・腫瘍学、皮膚科、眼科

世界の光開始剤市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、DUSA Pharmaceuticals、Bausch Health、Beiersdorf、Soligenix、Theralase Technologies、Quest Pharmatech、Galderma、Biofrontera

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、光開始剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な光開始剤メーカーの企業概要、2019年～2022年までの光開始剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な光開始剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別光開始剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの光開始剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での光開始剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および光開始剤の産業チェーンを掲載しています。
・第13、14、15章では、光開始剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 光開始剤の概要
- 種類別分析（2017年vs2021年vs2028年）：フォトフリン、レブラン、メトビックス、その他
- 用途別分析（2017年vs2021年vs2028年）：腫瘍学、皮膚科、眼科
- 世界の光開始剤市場規模・予測
- 世界の光開始剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi、DUSA Pharmaceuticals、Bausch Health、Beiersdorf、Soligenix、Theralase Technologies、Quest Pharmatech、Galderma、Biofrontera
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：フォトフリン、レブラン、メトビックス、その他
・用途別分析2017年-2028年：腫瘍学、皮膚科、眼科
・光開始剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・光開始剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・光開始剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・光開始剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・光開始剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Photoinitiator Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Photoinitiator Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Oncology accounting for % of the Photoinitiator Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Photofrin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Photoinitiator Drug include Sanofi, DUSA Pharmaceuticals, Bausch Health, Beiersdorf, and Soligenix, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Photoinitiator Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Photofrin
Levulan
Metvix
Others
Market segment by Application can be divided into
Oncology
Dermatology
Ophthalmology
The key market players for global Photoinitiator Drug market are listed below:
Sanofi
DUSA Pharmaceuticals
Bausch Health
Beiersdorf
Soligenix
Theralase Technologies
Quest Pharmatech
Galderma
Biofrontera
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Photoinitiator Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Photoinitiator Drug, with price, sales, revenue and global market share of Photoinitiator Drug from 2019 to 2022.
Chapter 3, the Photoinitiator Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Photoinitiator Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Photoinitiator Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Photoinitiator Drug.
Chapter 13, 14, and 15, to describe Photoinitiator Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Photoinitiator Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Photoinitiator Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Photofrin
1.2.3 Levulan
1.2.4 Metvix
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Photoinitiator Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Dermatology
1.3.4 Ophthalmology
1.4 Global Photoinitiator Drug Market Size & Forecast
1.4.1 Global Photoinitiator Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Photoinitiator Drug Sales in Volume (2017-2028)
1.4.3 Global Photoinitiator Drug Price (2017-2028)
1.5 Global Photoinitiator Drug Production Capacity Analysis
1.5.1 Global Photoinitiator Drug Total Production Capacity (2017-2028)
1.5.2 Global Photoinitiator Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Photoinitiator Drug Market Drivers
1.6.2 Photoinitiator Drug Market Restraints
1.6.3 Photoinitiator Drug Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Photoinitiator Drug Product and Services
2.1.4 Sanofi Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 DUSA Pharmaceuticals
2.2.1 DUSA Pharmaceuticals Details
2.2.2 DUSA Pharmaceuticals Major Business
2.2.3 DUSA Pharmaceuticals Photoinitiator Drug Product and Services
2.2.4 DUSA Pharmaceuticals Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Photoinitiator Drug Product and Services
2.3.4 Bausch Health Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Beiersdorf
2.4.1 Beiersdorf Details
2.4.2 Beiersdorf Major Business
2.4.3 Beiersdorf Photoinitiator Drug Product and Services
2.4.4 Beiersdorf Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Soligenix
2.5.1 Soligenix Details
2.5.2 Soligenix Major Business
2.5.3 Soligenix Photoinitiator Drug Product and Services
2.5.4 Soligenix Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Theralase Technologies
2.6.1 Theralase Technologies Details
2.6.2 Theralase Technologies Major Business
2.6.3 Theralase Technologies Photoinitiator Drug Product and Services
2.6.4 Theralase Technologies Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Quest Pharmatech
2.7.1 Quest Pharmatech Details
2.7.2 Quest Pharmatech Major Business
2.7.3 Quest Pharmatech Photoinitiator Drug Product and Services
2.7.4 Quest Pharmatech Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Galderma
2.8.1 Galderma Details
2.8.2 Galderma Major Business
2.8.3 Galderma Photoinitiator Drug Product and Services
2.8.4 Galderma Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biofrontera
2.9.1 Biofrontera Details
2.9.2 Biofrontera Major Business
2.9.3 Biofrontera Photoinitiator Drug Product and Services
2.9.4 Biofrontera Photoinitiator Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Photoinitiator Drug Breakdown Data by Manufacturer
3.1 Global Photoinitiator Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Photoinitiator Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Photoinitiator Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Photoinitiator Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Photoinitiator Drug Manufacturer Market Share in 2021
3.5 Global Photoinitiator Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Photoinitiator Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Photoinitiator Drug Market Size by Region
4.1.1 Global Photoinitiator Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Photoinitiator Drug Revenue by Region (2017-2028)
4.2 North America Photoinitiator Drug Revenue (2017-2028)
4.3 Europe Photoinitiator Drug Revenue (2017-2028)
4.4 Asia-Pacific Photoinitiator Drug Revenue (2017-2028)
4.5 South America Photoinitiator Drug Revenue (2017-2028)
4.6 Middle East and Africa Photoinitiator Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Photoinitiator Drug Sales in Volume by Type (2017-2028)
5.2 Global Photoinitiator Drug Revenue by Type (2017-2028)
5.3 Global Photoinitiator Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Photoinitiator Drug Sales in Volume by Application (2017-2028)
6.2 Global Photoinitiator Drug Revenue by Application (2017-2028)
6.3 Global Photoinitiator Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Photoinitiator Drug Sales by Type (2017-2028)
7.2 North America Photoinitiator Drug Sales by Application (2017-2028)
7.3 North America Photoinitiator Drug Market Size by Country
7.3.1 North America Photoinitiator Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Photoinitiator Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Photoinitiator Drug Sales by Type (2017-2028)
8.2 Europe Photoinitiator Drug Sales by Application (2017-2028)
8.3 Europe Photoinitiator Drug Market Size by Country
8.3.1 Europe Photoinitiator Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Photoinitiator Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Photoinitiator Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Photoinitiator Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Photoinitiator Drug Market Size by Region
9.3.1 Asia-Pacific Photoinitiator Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Photoinitiator Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Photoinitiator Drug Sales by Type (2017-2028)
10.2 South America Photoinitiator Drug Sales by Application (2017-2028)
10.3 South America Photoinitiator Drug Market Size by Country
10.3.1 South America Photoinitiator Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Photoinitiator Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Photoinitiator Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Photoinitiator Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Photoinitiator Drug Market Size by Country
11.3.1 Middle East & Africa Photoinitiator Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Photoinitiator Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Photoinitiator Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Photoinitiator Drug
12.3 Photoinitiator Drug Production Process
12.4 Photoinitiator Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Photoinitiator Drug Typical Distributors
13.3 Photoinitiator Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Photoinitiator Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Photoinitiator Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Photoinitiator Drug Product and Services
Table 6. Sanofi Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. DUSA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. DUSA Pharmaceuticals Major Business
Table 9. DUSA Pharmaceuticals Photoinitiator Drug Product and Services
Table 10. DUSA Pharmaceuticals Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 12. Bausch Health Major Business
Table 13. Bausch Health Photoinitiator Drug Product and Services
Table 14. Bausch Health Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Beiersdorf Basic Information, Manufacturing Base and Competitors
Table 16. Beiersdorf Major Business
Table 17. Beiersdorf Photoinitiator Drug Product and Services
Table 18. Beiersdorf Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Soligenix Basic Information, Manufacturing Base and Competitors
Table 20. Soligenix Major Business
Table 21. Soligenix Photoinitiator Drug Product and Services
Table 22. Soligenix Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Theralase Technologies Basic Information, Manufacturing Base and Competitors
Table 24. Theralase Technologies Major Business
Table 25. Theralase Technologies Photoinitiator Drug Product and Services
Table 26. Theralase Technologies Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Quest Pharmatech Basic Information, Manufacturing Base and Competitors
Table 28. Quest Pharmatech Major Business
Table 29. Quest Pharmatech Photoinitiator Drug Product and Services
Table 30. Quest Pharmatech Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Galderma Basic Information, Manufacturing Base and Competitors
Table 32. Galderma Major Business
Table 33. Galderma Photoinitiator Drug Product and Services
Table 34. Galderma Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biofrontera Basic Information, Manufacturing Base and Competitors
Table 36. Biofrontera Major Business
Table 37. Biofrontera Photoinitiator Drug Product and Services
Table 38. Biofrontera Photoinitiator Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Photoinitiator Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Photoinitiator Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Photoinitiator Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Photoinitiator Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Photoinitiator Drug Production Site of Key Manufacturer
Table 44. Photoinitiator Drug New Entrant and Capacity Expansion Plans
Table 45. Photoinitiator Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Photoinitiator Drug Sales by Region (2017-2022) & (K Units)
Table 47. Global Photoinitiator Drug Sales by Region (2023-2028) & (K Units)
Table 48. Global Photoinitiator Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Photoinitiator Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 51. Global Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 52. Global Photoinitiator Drug Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Photoinitiator Drug Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Photoinitiator Drug Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Photoinitiator Drug Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 57. Global Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 58. Global Photoinitiator Drug Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Photoinitiator Drug Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Photoinitiator Drug Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Photoinitiator Drug Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Photoinitiator Drug Sales by Country (2017-2022) & (K Units)
Table 63. North America Photoinitiator Drug Sales by Country (2023-2028) & (K Units)
Table 64. North America Photoinitiator Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Photoinitiator Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 67. North America Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 68. North America Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 69. North America Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 70. Europe Photoinitiator Drug Sales by Country (2017-2022) & (K Units)
Table 71. Europe Photoinitiator Drug Sales by Country (2023-2028) & (K Units)
Table 72. Europe Photoinitiator Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Photoinitiator Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 75. Europe Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 76. Europe Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 77. Europe Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Photoinitiator Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Photoinitiator Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Photoinitiator Drug Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Photoinitiator Drug Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 86. South America Photoinitiator Drug Sales by Country (2017-2022) & (K Units)
Table 87. South America Photoinitiator Drug Sales by Country (2023-2028) & (K Units)
Table 88. South America Photoinitiator Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Photoinitiator Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 91. South America Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 92. South America Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 93. South America Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Photoinitiator Drug Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Photoinitiator Drug Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Photoinitiator Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Photoinitiator Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Photoinitiator Drug Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Photoinitiator Drug Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Photoinitiator Drug Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Photoinitiator Drug Sales by Application (2023-2028) & (K Units)
Table 102. Photoinitiator Drug Raw Material
Table 103. Key Manufacturers of Photoinitiator Drug Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Photoinitiator Drug Typical Distributors
Table 107. Photoinitiator Drug Typical Customers
List of Figures
Figure 1. Photoinitiator Drug Picture
Figure 2. Global Photoinitiator Drug Revenue Market Share by Type in 2021
Figure 3. Photofrin
Figure 4. Levulan
Figure 5. Metvix
Figure 6. Others
Figure 7. Global Photoinitiator Drug Revenue Market Share by Application in 2021
Figure 8. Oncology
Figure 9. Dermatology
Figure 10. Ophthalmology
Figure 11. Global Photoinitiator Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Photoinitiator Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Photoinitiator Drug Sales (2017-2028) & (K Units)
Figure 14. Global Photoinitiator Drug Price (2017-2028) & (US$/Unit)
Figure 15. Global Photoinitiator Drug Production Capacity (2017-2028) & (K Units)
Figure 16. Global Photoinitiator Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Photoinitiator Drug Market Drivers
Figure 18. Photoinitiator Drug Market Restraints
Figure 19. Photoinitiator Drug Market Trends
Figure 20. Global Photoinitiator Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Photoinitiator Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Photoinitiator Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Photoinitiator Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Photoinitiator Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Photoinitiator Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Photoinitiator Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Photoinitiator Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Photoinitiator Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Photoinitiator Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Photoinitiator Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Photoinitiator Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Photoinitiator Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Photoinitiator Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Photoinitiator Drug Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Photoinitiator Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Photoinitiator Drug Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Photoinitiator Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Photoinitiator Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Photoinitiator Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Photoinitiator Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Photoinitiator Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Photoinitiator Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Photoinitiator Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Photoinitiator Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Photoinitiator Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Photoinitiator Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Photoinitiator Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Photoinitiator Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Photoinitiator Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Photoinitiator Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Photoinitiator Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Photoinitiator Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Photoinitiator Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Photoinitiator Drug in 2021
Figure 79. Manufacturing Process Analysis of Photoinitiator Drug
Figure 80. Photoinitiator Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • フォトレジスト光重合開始剤のグローバル市場展望 2023年-2029年：LCDフォトレジスト光重合開始剤、半導体フォトレジスト光重合開始剤、PCBフォトレジスト光重合開始剤
  • 世界の半導体光開始剤市場2022年：市場規模予測（～2028年）
  • 高分子光重合開始剤のグローバル市場展望 2023年-2029年：サイドチェーン開裂型、メインチェーン開裂型、サイドチェーン水素吸蔵型、メインチェーン水素吸蔵型
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19543 )"世界の光開始剤市場2022年：市場規模予測（～2028年）" (英文：Global Photoinitiator Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。